YSB Inc. (HKG:9885)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.34
+0.08 (1.52%)
Apr 2, 2026, 1:54 PM HKT
Market Cap3.57B -25.2%
Revenue (ttm)23.34B +17.1%
Net Income170.22M +409.7%
EPS0.24 +373.0%
Shares Out679.47M
PE Ratio21.49
Forward PEn/a
Dividend0.13 (2.45%)
Ex-Dividend DateMay 26, 2026
Volume687,400
Average Volume4,240,986
Open5.23
Previous Close5.26
Day's Range5.19 - 5.39
52-Week Range3.56 - 12.66
Beta1.00
RSI60.31
Earnings DateMar 23, 2026

About YSB Inc.

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qu... [Read more]

Sector Healthcare
Founded 2015
Employees 6,620
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9885
Full Company Profile

Financial Performance

In 2025, YSB Inc.'s revenue was 20.97 billion, an increase of 17.13% compared to the previous year's 17.90 billion. Earnings were 152.97 million, an increase of 409.66%.

Financial numbers in CNY Financial Statements